Trial
NCT05010460
Study of Roxadustat for Reducing the Incidence of Acute Kidney Injury After Coronary Artery Bypass Grafting
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Peking Union Medical College Hospital
Collaborators
Beijing Hospital
Condition
Coronary Artery Bypass
Intervention
Roxadustat
Why stopped
slow enrollment and inability to reach the planned sample size within the expected timeframe
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-12-09